Explainable Artificial Intelligence (XAI) has become an increasingly important area of research, particularly as machine learning models are deployed in high-stakes domains. Among various XAI approaches, SHAP (SHapley Additive exPlanations) has gained prominence due to its ability to provide both global and local explanations across different machine learning models. While SHAP effectively visualizes feature importance, it often lacks contextual explanations that are meaningful for end-users, especially those without technical backgrounds. To address this gap, we propose a Python package that extends SHAP by integrating it with a large language model (LLM), specifically OpenAI's GPT, to generate contextualized textual explanations. This integration is guided by user-defined parameters (such as feature aliases, descriptions, and additional background) to tailor the explanation to both the model context and the user perspective. We hypothesize that this enhancement can improve the perceived understandability of SHAP explanations. To evaluate the effectiveness of the proposed package, we applied it in a healthcare-related case study and conducted user evaluations involving real end-users. The results, based on Likert-scale surveys and follow-up interviews, indicate that the generated explanations were perceived as more understandable and contextually appropriate compared to visual-only outputs. While the findings are preliminary, they suggest that combining visualization with contextualized text may support more user-friendly and trustworthy model explanations.

Computational Imaging Research Lab, Department of Biomedical Imaging and Image - guided Therapy, Medical University of Vienna, Austria . Abstract (2 50 words) Background We aimed to quantify hepatic vessel volumes across chronic liver disease stages and healthy controls using deep learning - based magnetic resonance imaging ( MRI) analysis, and assess correlations with biomarkers for liver (dys)function and fibrosis/portal hypertension. Methods We assessed retrospectively healthy controls, non - advanced and advanced chronic liver disease (ACLD) patients using a 3D U - Net model for hepatic vessel segmentation on portal venous phase gadoxetic acid - enhanced 3 - T MRI. Total (TVVR), hepatic (HVVR), and intrahepatic portal vein - to - volume ratios (PVVR) were compared between groups and c orrelat ed with: a lbumin - b ilirubin [ ALBI ] and "m odel for e nd - s tage l iver d isease - s odium " [ MELD - Na ] s core) and fibrosis/portal hypertension (Fibrosis - 4 [ FIB - 4 ] Score, liver stiffness measurement [ LSM ], hepatic venous pressure gradient [ HVPG ], platelet count [ PLT ], and spleen volume. Results We included 197 subjects, aged 54.9 13.8 years (mean standard deviation), 111 males ( 56 .3 TVVR and HVVR were highest in controls (3.9; 2.1), intermediate in non - ACLD (2.8; 1.7), and lowest in ACLD patients (2.3; 1.0) ( p 0. 001) . PVVR was reduced in both non - ACLD and ACLD patients (both 1.2) compared to controls (1.7) ( p 0. 001), but showed no difference between CLD groups ( p = 0.999) . TVVR and PVVR showed similar but weaker correlations. Conclusion s Deep learning - based hepatic vessel volumetry demonstrate d differences between healthy liver and chronic liver disease stages and shows correlations with established markers of disease severity. Relevance s tatement Hepatic vessel volumetry demonstrates differences between healthy liver and chronic liver disease stages, potentially serving as a non - invasive imaging biomarker.

Medical fact-checking has become increasingly critical as more individuals seek medical information online. However, existing datasets predominantly focus on human-generated content, leaving the verification of content generated by large language models (LLMs) relatively unexplored. To address this gap, we introduce MedFact, the first evidence-based Chinese medical fact-checking dataset of LLM-generated medical content. It consists of 1,321 questions and 7,409 claims, mirroring the complexities of real-world medical scenarios. We conduct comprehensive experiments in both in-context learning (ICL) and fine-tuning settings, showcasing the capability and challenges of current LLMs on this task, accompanied by an in-depth error analysis to point out key directions for future research. Our dataset is publicly available at https://github.com/AshleyChenNLP/MedFact.

Liver diseases are a serious health concern in the world, which requires precise and timely diagnosis to enhance the survival chances of patients. The current literature implemented numerous machine learning and deep learning models to classify liver diseases, but most of them had some issues like high misclassification error, poor interpretability, prohibitive computational expense, and lack of good preprocessing strategies. In order to address these drawbacks, we introduced StackLiverNet in this study; an interpretable stacked ensemble model tailored to the liver disease detection task. The framework uses advanced data preprocessing and feature selection technique to increase model robustness and predictive ability. Random undersampling is performed to deal with class imbalance and make the training balanced. StackLiverNet is an ensemble of several hyperparameter-optimized base classifiers, whose complementary advantages are used through a LightGBM meta-model. The provided model demonstrates excellent performance, with the testing accuracy of 99.89%, Cohen Kappa of 0.9974, and AUC of 0.9993, having only 5 misclassifications, and efficient training and inference speeds that are amenable to clinical practice (training time 4.2783 seconds, inference time 0.1106 seconds). Besides, Local Interpretable Model-Agnostic Explanations (LIME) are applied to generate transparent explanations of individual predictions, revealing high concentrations of Alkaline Phosphatase and moderate SGOT as important observations of liver disease. Also, SHAP was used to rank features by their global contribution to predictions, while the Morris method confirmed the most influential features through sensitivity analysis.

We present the design process and findings of the pre-conference workshop at the Machine Learning for Healthcare Conference (2024) entitled Red Teaming Large Language Models for Healthcare, which took place on August 15, 2024. Conference participants, comprising a mix of computational and clinical expertise, attempted to discover vulnerabilities -- realistic clinical prompts for which a large language model (LLM) outputs a response that could cause clinical harm. Red-teaming with clinicians enables the identification of LLM vulnerabilities that may not be recognised by LLM developers lacking clinical expertise. We report the vulnerabilities found, categorise them, and present the results of a replication study assessing the vulnerabilities across all LLMs provided.

Liver cirrhosis is an insidious condition involving the substitution of normal liver tissue with fibrous scar tissue and causing major health complications. The conventional method of diagnosis using liver biopsy is invasive and, therefore, inconvenient for use in regular screening. In this paper,we present a hybrid model that combines machine learning techniques with clinical data and ultrasoundscans to improve liver fibrosis and cirrhosis detection accuracy is presented. The model integrates fixed blood test probabilities with deep learning model predictions (DenseNet-201) for ultrasonic images. The combined hybrid model achieved an accuracy of 92.5%. The findings establish the viability of the combined model in enhancing diagnosis accuracy and supporting early intervention in liver disease care.

Liver diseases pose a significant global health burden, impacting many individuals and having substantial economic and social consequences. Rising liver problems are considered a fatal disease in many countries, such as Egypt and Moldova. This study aims to develop a diagnosis and treatment model for liver disease using Basic Formal Ontology (BFO), Patient Clinical Data (PCD) ontology, and detection rules derived from a decision tree algorithm. For the development of the ontology, the National Viral Hepatitis Control Program (NVHCP) guidelines were used, which made the ontology more accurate and reliable. The Apache Jena framework uses batch processing to detect events based on these rules. Based on the event detected, queries can be directly processed using SPARQL. We convert these Decision Tree (DT) and medical guidelines-based rules into Semantic Web Rule Language (SWRL) to operationalize the ontology. Using this SWRL in the ontology to predict different types of liver disease with the help of the Pellet and Drools inference engines in Protege Tools, a total of 615 records were taken from different liver diseases. After inferring the rules, the result can be generated for the patient according to the rules, and other patient-related details, along with different precautionary suggestions, can be obtained based on these results. These rules can make suggestions more accurate with the help of Explainable Artificial Intelligence (XAI) with open API-based suggestions. When the patient has prescribed a medical test, the model accommodates this result using optical character recognition (OCR), and the same process applies when the patient has prescribed a further medical suggestion according to the test report. These models combine to form a comprehensive Decision Support System (DSS) for the diagnosis of liver disease.

Chronic liver disease represents a significant health challenge worldwide and accurate prognostic evaluations are essential for personalized treatment plans. Recent evidence suggests that integrating multimodal data, such as computed tomography imaging, radiomic features, and clinical information, can provide more comprehensive prognostic information. However, modalities have an inherent heterogeneity, and incorporating additional modalities may exacerbate the challenges of heterogeneous data fusion. Moreover, existing multimodal fusion methods often struggle to adapt to richer medical modalities, making it difficult to capture inter-modal relationships. To overcome these limitations, We present the Triple-Modal Interaction Chronic Liver Network (TMI-CLNet). Specifically, we develop an Intra-Modality Aggregation module and a Triple-Modal Cross-Attention Fusion module, which are designed to eliminate intra-modality redundancy and extract cross-modal information, respectively. Furthermore, we design a Triple-Modal Feature Fusion loss function to align feature representations across modalities. Extensive experiments on the liver prognosis dataset demonstrate that our approach significantly outperforms existing state-of-the-art unimodal models and other multi-modal techniques. Our code is available at https://github.com/Mysterwll/liver.git.

Globally, chronic liver disease continues to be a major health concern that requires precise predictive models for prompt detection and treatment. Using the Indian Liver Patient Dataset (ILPD) from the University of California at Irvine's UCI Machine Learning Repository, a number of machine learning algorithms are investigated in this study. The main focus of our research is this dataset, which includes the medical records of 583 patients, 416 of whom have been diagnosed with liver disease and 167 of whom have not. There are several aspects to this work, including feature extraction and dimensionality reduction methods like Linear Discriminant Analysis (LDA), Factor Analysis (FA), t-distributed Stochastic Neighbour Embedding (t-SNE), and Uniform Manifold Approximation and Projection (UMAP). The purpose of the study is to investigate how well these approaches work for converting high-dimensional datasets and improving prediction accuracy. To assess the prediction ability of the improved models, a number of classification methods were used, such as Multi-layer Perceptron, Random Forest, K-nearest neighbours, and Logistic Regression. Remarkably, the improved models performed admirably, with Random Forest having the highest accuracy of 98.31\% in 10-fold cross-validation and 95.79\% in train-test split evaluation. Findings offer important new perspectives on the choice and use of customized feature extraction and dimensionality reduction methods, which improve predictive models for patients with chronic liver disease.

Non-alcoholic fatty liver disease (NAFLD) is one of the most widespread liver disorders on a global scale, posing a significant threat of progressing to more severe conditions like nonalcoholic steatohepatitis (NASH), liver fibrosis, cirrhosis, and hepatocellular carcinoma. Diagnosing and staging NAFLD presents challenges due to its non-specific symptoms and the invasive nature of liver biopsies. Our research introduces a novel artificial intelligence cascade model employing ensemble learning and feature fusion techniques. We developed a non-invasive, robust, and reliable diagnostic artificial intelligence tool that utilizes anthropometric and laboratory parameters, facilitating early detection and intervention in NAFLD progression. Our novel artificial intelligence achieved an 86% accuracy rate for the NASH steatosis staging task (non-NASH, steatosis grade 1, steatosis grade 2, and steatosis grade 3) and an impressive 96% AUC-ROC for distinguishing between NASH (steatosis grade 1, grade 2, and grade3) and non-NASH cases, outperforming current state-of-the-art models. This notable improvement in diagnostic performance underscores the potential application of artificial intelligence in the early diagnosis and treatment of NAFLD, leading to better patient outcomes and a reduced healthcare burden associated with advanced liver disease.